Jeremy Yarwood

CIK: 0002161176

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NEOG

NEOGEN CORP

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

NEOG
NEOGEN CORP
Nov 4, 2026
Sale(S)
Direct
9.1K shares at avg. $12.67$115K
NEOG
NEOGEN CORP
Nov 3, 2026
Exercise(M)
Direct
16.2K shares at avg. $11.82$192K
NEOG
NEOGEN CORP
Nov 3, 2026
Tax Payment(F)
Direct
7.2K shares at avg. $11.82$85K

		Type	Shares	Price		Ownership
Nov 4, 2026	NEOG NEOGEN CORP	Sale(S)	9,051	$12.67	$114,676	Direct
Nov 3, 2026	NEOG NEOGEN CORP	Exercise(M)	16,207	$11.82	$191,567	Direct
Nov 3, 2026	NEOG NEOGEN CORP	Tax Payment(F)	7,156	$11.82	$84,584	Direct

1-3 of 3 transactions

About Yarwood Jeremy

Yarwood Jeremy (SEC CIK 0002161176) files insider reports with the SEC as Chief Scientific Officer of NEOGEN CORP (NEOG).

Signal8 holds 2 ownership filings by Yarwood Jeremy (1 Form 3, 1 Form 4), filed between Oct 21, 2026 and Nov 4, 2026. Those filings report 3 transactions, from Nov 3, 2026 to Nov 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Yarwood Jeremy's filings is in LANSING, MI.

Recent filings by Yarwood Jeremy

Nov 4, 2026: Open-market sale of NEOG shares (Form 4, code S).
Nov 3, 2026: Option exercise of NEOG shares (Form 4, code M).
Nov 3, 2026: Tax withholding of NEOG shares (Form 4, code F).

Other insiders filing for NEOGEN CORP (NEOG)

Freels Joe B, Chief Commercial Officer
Hastings Gregory S, VP, Animal Health
Woteki Catherine E, Director
RODRIGUEZ RAFAEL A, Director
Burke Kevin M, Chief HR Officer
Gupta Aashima, Director

How to read Form 4 transaction codes